|  | 
         
            |  | 
         
            |  | A BILL TO BE ENTITLED | 
         
            |  | AN ACT | 
         
            |  | relating to the redistribution of donated prepackaged prescription | 
         
            |  | drugs. | 
         
            |  | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | 
         
            |  | SECTION 1.  Section 442.001, Health and Safety Code, is | 
         
            |  | amended by adding Subdivision (6-a) to read as follows: | 
         
            |  | (6-a)  "Prepackage" means the act of repackaging and | 
         
            |  | relabeling varying quantities of prescription drugs from a | 
         
            |  | manufacturer's original commercial container into a prescription | 
         
            |  | container, unit-dose packaging, or a multi-compartment container | 
         
            |  | for a pharmacist to dispense to a consumer. | 
         
            |  | SECTION 2.  Subchapter B, Chapter 442, Health and Safety | 
         
            |  | Code, is amended by adding Section 442.0515 to read as follows: | 
         
            |  | Sec. 442.0515.  REDISTRIBUTION OF DONATED PREPACKAGED | 
         
            |  | PRESCRIPTION DRUGS.  (a)  A participating provider may dispense to a | 
         
            |  | recipient donated prescription drugs that are prepackaged and | 
         
            |  | labeled in accordance with this section and rules adopted by the | 
         
            |  | Texas State Board of Pharmacy. | 
         
            |  | (b)  A prepackaged prescription drug a participating | 
         
            |  | provider dispenses to a recipient must contain a label that | 
         
            |  | includes: | 
         
            |  | (1)  the drug's brand name or, for a generic version of | 
         
            |  | the drug, the drug's generic name and the manufacturer or | 
         
            |  | distributor of the drug; | 
         
            |  | (2)  the amount of the drug in a given dose; | 
         
            |  | (3)  the drug's lot number; | 
         
            |  | (4)  the earliest expiration date of the drug for that | 
         
            |  | drug lot number; and | 
         
            |  | (5)  the quantity of any drug the provider dispenses in | 
         
            |  | more than one dose. | 
         
            |  | (c)  A participating provider shall maintain a record of each | 
         
            |  | prepackaged prescription drug dispensed to a recipient.  The record | 
         
            |  | must include: | 
         
            |  | (1)  the drug's name, the amount of the drug in a given | 
         
            |  | dose, and the dosage size or frequency; | 
         
            |  | (2)  the provider's lot number for that drug; | 
         
            |  | (3)  the drug's manufacturer or distributor; | 
         
            |  | (4)  the manufacturer's lot number for that drug; | 
         
            |  | (5)  the expiration dates of the drug from that drug's | 
         
            |  | lot number; | 
         
            |  | (6)  the quantity of the drug in each prepackaged unit; | 
         
            |  | (7)  the number of prepackaged units that include the | 
         
            |  | drug; | 
         
            |  | (8)  the date the drug was prepackaged; | 
         
            |  | (9)  the name, initials, or written or electronic | 
         
            |  | signature of the individual who prepackaged the drug; and | 
         
            |  | (10)  the written or electronic signature of the | 
         
            |  | pharmacist responsible for the drug's prepackaging. | 
         
            |  | SECTION 3.  As soon as practicable after the effective date | 
         
            |  | of this Act, the Texas State Board of Pharmacy shall adopt any rules | 
         
            |  | necessary to implement the changes in law made by this Act. | 
         
            |  | SECTION 4.  This Act takes effect September 1, 2023. |